Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,075,000
+$4,075,000 QoQ
Shares Held
625,000
0.0% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#42
of 290 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cercano Management LLC holds $34,052,181 across 4 Biotechnology names. DNLI ranks #1 (47.2% of the industry book) .
All Filings in DNLI
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,075,000 | 625,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,000,000 | 625,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,318,750 | 625,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,075,000 | 625,000 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $8,743,750 | 625,000 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $8,496,875 | 625,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $12,737,500 | 625,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,206,250 | 625,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,512,500 | 625,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,825,000 | 625,000 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $13,412,500 | 625,000 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $12,893,750 | 625,000 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $18,443,750 | 625,000 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $14,400,000 | 625,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,381,250 | 625,000 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||